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 ABSTRACT
Introduction: The Henoch-Schönlein purpura (HSP) is an immunoglobulin A (IgA)-mediated small-
vessel systemic vasculitis, rare in adults. The association with solid tumours has been described, 
especially with lung cancer. Case Report: We present the case of a 60-year-old Caucasian male, diag-
nosed with lung adenocarcinoma that underwent surgical resection without (neo)adjuvant theraphy. 
Two months latter he was admitted for abdominal pain, purpuric rash on his lower extremities and 
acute kidney injury, with serum creatinine (Scr) of 2 mg/dl. Urinalysis revealed haematuria and 24h 
proteinuria (P24h) of 1.5 g. The serum protein electrophoresis, complement components C3 and C4, 
circulating immune complexes, cryoglobulins, ANCA, ANA, anti-dsDNA and the remaining immunologic 
study as screening for viral infections (HCV, HBV and HIV) were negative. Renal ultrasound was normal 
and kidney biopsy revealed mild mesangial proliferation; 2 cellular glomerular crescents and 1 fibrinoid 
necrosis lesion; large amounts of red blood cell casts; lymphocytic infiltration in the intertubular inter-
stitial capillaries; moderate arteriolar hyalinosis. Immunofluorescence demonstrated mesangial and 
parietal deposits of IgA. The diagnosis of HSP was assumed, and the patient started prednisolone 1 
mg/kg/day. Ten months after diagnosis the patient’s baseline Scr is 1.4 mg/dl with P24h of 0.18g, 
without haematuria. Conclusion: Although this is a rare association and the exact mechanism behind 
the disease is yet unknown, physicians should be aware of it. The early recognition and treatment may 
prevent renal disease progression. 
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 INTRODUCTION
Henoch-Schönlein purpura (HSP) is an IgA-medi-
ated small-vessel systemic vasculitis with multiorgan 
involvement, but most notably affects the skin, joints, 
gastrointestinal tract and kidney1.  It is much more 
common in children but can also occur in adults2. 
Although the exact cause is presently unknown, 
malignancy has been reported as a causative factor, 
with pulmonary, prostatic and renal tumours being 
the most commonly associated3.
In this report, we present a rare case of HSP 
associated with lung adenocarcinoma. 
 CASE REPORT
We present the case of a 60-year-old Caucasian 
male, with a history of arterial hypertension, since 2013, 
controlled with bisoprolol, who was a 150 pack-year 
cigarette smoker. In January 2014, he had a diagnosis 
of right inferior lobe lung adenocarcinoma (pT2N1M0, 
without epidermal growth factor receptor gene muta-
tion) and underwent surgical resection without (neo)
adjuvant chemo- or radiotherapy. Two months later he 
was admitted to another hospital for abdominal pain. 
The abdominopelvic CT revealed a diffuse submucosal 
oedema of the ileum and ascending colon, and the 
endoscopic study demonstrated multiple mucosal ero-
sions in the same location. The intestinal biopsy was 
suggestive of a nonspecific inflammatory ileocolic dis-
ease. At that time, he developed a purpuric rash on 
his lower extremities, considered not relevant by a 
dermatologist, with no need of active treatment. There 
was no history of arthralgia or arthritis, the patient was 
not taking any new medication and did not have any 
known allergies. At this time point, his kidney function 
was normal (Scr of 0.65 mg/dl) and investigation for 
haemato-proteinuria was not done. The patient was 
discharged with the presumptive diagnosis of ischaemic 
colitis. Two weeks later he was readmitted with per-
sistent abdominal pain and referred to our Nephrology 
Department for acute kidney injury (Scr 2 mg/dl). 
On admission, he had no symptoms or signs of 
arthralgia, arthritis or purpuric rash, he was conscious, 
oriented, afebrile, blood pressure was 138/73 mmHg, 
skin and mucous membranes had normal coloration, 
he was hydrated and anicteric, with normal cardio-
pulmonary auscultation and innocent abdominal 
examination, without peripheral oedema. The remain-
der of his physical examination was unremarkable.  
 RESUMO
Introdução: A Púrpura de Henoch-Schönlein (PHS) é uma vasculite sistémica de pequenos vasos associada 
à deposição de imunoglobulina A (IgA), rara nos adultos. A sua associação com neoplasias sólidas está 
descrita, sendo a neoplasia do pulmão a mais frequentemente encontrada. Caso Clínico: Apresentamos o 
caso de um doente de 60 anos, com o diagnóstico de adenocarcinoma do pulmão submetido a ressecção 
cirúrgica sem terapêutica (neo)adjuvante. Dois meses depois, foi admitido por dor abdominal, púrpura 
palpável nos membros inferiores e lesão renal aguda, com creatinina plasmática (Pcr) de 2 mg/dl, hematúria 
e proteinúria/24h (P24h) de 1,5g.  A electroforese sérica, C3 e C4, pesquisa de imunocomplexos circulantes 
e crioglobulinas, ANA, anti-dsDNA e restante estudo imunológico, assim como as serologias virais (VHC, 
VHB, VIH), foram negativos. A ecografia renal era normal e a biópsia renal revelou glomérulos com discreta 
proliferação mesangial, 2 glomérulos com crescentes e 1 com necrose fibrinóide; numerosos cilindros 
hemáticos; presença de linfócitos nos capilares inter-tubulares; moderada hialinose arteriolar. A imunofluo-
rescência revelou depósitos mesangiais e parietais de IgA. Admitiu-se PHS e o doente iniciou prednisolona 
1 mg/kg/dia, encontrando-se 10 meses após diagnóstico com função renal estabilizada em Pcr 1,4 mg/dl e 
P24h 0,18g, sem hematúria. Conclusão: Embora a associação entre adenocarcinoma do pulmão e PHS seja 
rara e o seu mecanismo não esteja esclarecido, devemos estar atentos, dado que o reconhecimento e 
tratamento atempados podem evitar a progressão da doença renal.
Palavras-Chave: Insuficiência renal; neoplasia do pulmão; púrpura Henoch-Schönlein; vasculite.
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Initial laboratory testing results revealed abnormal 
levels of Scr (2.04 mg/dl - eGFR 34 ml/min/1.73m2, 
calculated by CKD-EPI creatinine equation), urea (84 
mg/dl) sodium (132 mEq/L), potassium (5.4 mEq/l) and 
phosphorous (5.3mg/dl). Serum levels of calcium, uric 
acid and lactate dehydrogenase were normal. The hae-
mogram presented haemoglobin of 9.4 g/dl (normocytic, 
normochromic), platelet count of 368x10^3mm3, and 
leukocytes of 11.1x10^9/L (neutrophil 68.4%, lympho-
cytes 24.3%, monocytes 6.3%, eosinophils 0.6%, baso-
phil 0.4%). Urinalysis showed haematuria (erythrocytes 
3+/hpf) and proteinuria (150 mg/dL), without epithelial 
cells or casts and the P24h was 1.5g.  
Protein electrophoresis and serum immunoglobu-
lins IgA, IgM and IgG were normal, and there was no 
evidence of monoclonal component. The subsequent 
findings were negative or normal for C3 and C4, ANA, 
anti-dsDNA, ANCA, cryoglobulin, rheumatoid factor, 
circulating immune complexes, HBsAg, anti-HCV, anti-
HIV. Blood and urine cultures were negative. 
Renal ultrasound revealed normal sized kidneys 
with normal parenchymal sinus differentiation. 
A renal biopsy was performed and a total of 13 
glomeruli were obtained. Two glomeruli showed com-
plete sclerosis due to ischaemia. The remaining glom-
eruli showed mild mesangial proliferation and in five 
glomeruli sclerosing proliferative lesions adherent to 
the Bowman capsule were present. In two of them, 
cellular glomerular crescents were defined (Fig. 1) 
and in one a fibrinoid necrosis lesion was present. 
Generalized tubular atrophy was observed with some 
tubular necrosis areas and large amounts of red blood 
cell casts. There was a mild inflammatory infiltrate 
with lymphocytic infiltration in the intertubular inter-
stitial capillaries. There was also moderate arteriolar 
hyalinosis. Congo red staining was negative, and the 
immunofluorescence in frozen section demonstrated 
mesangial and parietal deposits of IgA (Fig. 2) and 
λ chain (+/++). Skin biopsy was normal.
Diagnosis of HSP was made and the patient started 
prednisolone 1 mg/kg/day (60 mg/day), with no other 
immunosuppressive agent due to his recent lung 
cancer diagnosis. At discharge, he was clinically 
improved. Six months after initiation of prednisolone 
therapy, tapered to 20 mg/day, he was clinically 
asymptomatic, with Scr of 1.67 mg/dl and P24h of 
0.5 g without evidence of haematuria. Currently, 
almost one year after, the patient has stabilized 
kidney function, with Scr of 1.4 mg/dl and P24h of 
0.18 g, with prednisolone 2.5 mg/day and without 
any signs of recurrence of the cancer.
 DISCUSSION
Henoch-Schönlein purpura is an IgA-mediated 
small-vessel systemic vasculitis, which may affect 
the skin, joints, gastrointestinal tract and kidneys. 
The likely pathophysiology mechanism behind it 
Figure 1
Glomerular crescent (Masson Trichrome stain; x400).
 
Figure 2
Mesangial and parietal deposits of IgA (immunofluorescence; x400).
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involves a process by which the IgA and C3 complexes 
become deposited on arterioles, capillaries and 
venules. 
The diagnosis of HSP is established on the com-
bination of symptoms, typically characterized by a 
tetrad of clinical features: purpura, arthralgia, abdom-
inal pain and renal impairment. The HSP occurs more 
often in children than in adults, who frequently 
develop a more severe clinical syndrome and renal 
impairment2.  Also, the outcome of HSP predomi-
nantly depends on the degree of kidney involve-
ment4. The diagnostic criteria for HSP, according to 
the American College of Rheumatology (ACR), are 
palpable purpura, bowel angina, histological changes 
of leukocytoclastic vasculitis and age 20 years or 
younger at onset. The diagnosis of HSP is 81.7% 
sensitive and 87.7% specific when two or more of 
these criteria are present5. In our patient, all criteria 
were present except age, thereby fulfilling the diag-
nosis of HSP according to the ACR criteria. 
Gastrointestinal involvement is frequent in HSP 
patients, occurring in about two-third of cases, and 
abdominal pain is nearly constant. In a recent Span-
ish series, the main clinical manifestations were 
abdominal pain (100%), nausea and vomiting (14.4%), 
melena and/or rectorrhagia (12.9%), and positive 
stool guaiac test (10.3%)6. Abdominal symptoms are 
possibly secondary to bowel oedema and ischaemia, 
with descending duodenum and the terminal ileum 
being the most frequently involved areas, although 
it may also affect the esophagus, stomach and colon7. 
Bowel wall thickening with engorgement of mesen-
teric vessels commonly represents CT scan findings 
and endoscopic features include diffuse mucosal 
redness, petechiae, haemorrhagic erosions and 
ulcers8. 
Our patient presented with abdominal pain, and 
the CT scan showed submucosal oedema of the ileum 
and ascending colon with an endoscopic study reveal-
ing diffuse multiple mucosal erosions in the same 
location. These findings are compatible with those 
described for gastrointestinal involvement in HSP 
patients. Additionally, it was reported that vasculitic 
endoscopic lesions are documented in only some 
patients with abdominal symptoms in HSP9. A pos-
sible reason for this is that endoscopic biopsies are 
often superficial and miss the submucosal vessels, 
thereby missing the vasculitis signs and only 
revealing nonspecific inflammation7,10. This may 
explain the finding in our patient’s intestinal biopsy 
specimen of nonspecific inflammation without 
vasculitis.
The aetiology of HSP remains unknown and vari-
ous triggers have been hypothesized, including bac-
terial or viral infections, foods, allergens, autoimmune 
connective tissue disease and drugs11.  In the litera-
ture, associations between solid malignancies and 
HSP have been reported in cases where a “tradi-
tional” triggering factor could not be found12. 
Although haematological malignancies are more 
frequent than solid tumours in all types of vasculitis, 
solid tumours are the most commonly associated 
with HSP and lung cancer has been the most 
described. As reported by Zurada et al3, 31 patients 
with HSP had underlying malignancies, among which 
solid tumours accounted for 61% and lung cancer 
for 25%. However, no temporal correlations between 
the onset of the HSP and the cancer diagnosis have 
been defined.
To the best of our knowledge, only 14 cases of 
HSP associated with lung cancer are reported to 
date4. The most common histological diagnoses were 
squamous cell (n = 8), adenocarcinoma (n = 3) and 
small cell (n = 3).  In the majority of these cases, 
the onset of HSP was synchronous or preceded the 
tumour and, less commonly, the HSP symptoms 
appeared after the diagnosis of lung cancer. In our 
case, the patient had no correlation with the “tradi-
tional” recognized triggering factors. Onset of HSP 
occurred 2 months after the lung cancer diagnosis 
and surgical resection, making it likely that the HSP 
was associated with the tumour. 
The exact correlation between HSP and malignan-
cies remains obscure, but it is possible that the 
generation and expression of tumour-associated 
antigen stimulate the immune system to produce 
aberrant antibodies. These antibodies and antigens 
react and lead to the formation of immune com-
plexes that can deposit within vessel walls. Further-
more, tumour-associated antigens reduce the clear-
ance of circulating immune complexes13,14 and they 
can also cause lymphocytes dysfunction and lead 
to the immunoglobulin subtypes shifting from IgM 
to IgA, which may subsequently cause the release 
of a large number of aberrant inflammatory cyto-
kines, eventualy resulting in vascular inflammation15. 
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The treatment of malignant tumours may also cause 
the occurrence of HSP. It is possible that radio-
therapy, chemotherapy, and surgical resection 
change the surface antigens of tumour cells or that 
tumour-associated antigens are released within the 
tumour cells following their destruction16. In the 
present study, the patient developed HSP after sur-
gical resection and although the exact correlation 
between HSP and lung cancer remains poorly under-
stood, we can postulate that the occurrence of HSP 
in this patient may be attributed to the malignancy 
itself, even more on the fact that another triggering 
factor could not be found.
Treatment for HSP associated with lung cancer 
has not been well-defined. In some case reports, 
therapies for lung cancer induced HSP remission, 
whereas in others steroids were required for HSP 
improvement, as in our case. We were reluctant to 
use a more aggressive immunosuppressive treatment 
attending to the recent lung cancer diagnosis, even 
though it was seemingly controlled with surgery. 
Nevertheless, we believe that the corticosteroid 
therapy contributed to the patient’s clinical and labo-
ratory improvement.
We report a rare case of HSP associated with 
pulmonary adenocarcinoma and to the best of our 
knowledge this is the fourth case described in the 
literature. 
Although this is a rare association and the exact 
mechanism behind it is yet unknown, physicians 
should be aware of it. The early recognition and 
treatment of this condition may prevent the progres-
sion of kidney disease to a more advanced stage, 
where the patient’s condition and the renal outcome 
are poorer. It remains unclear what is the optimum 
treatment for HSP associated with malignancy, but 
corticosteroid therapy seems to have been beneficial 
in the clinical management and improvement of our 
patient.
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